Karen Dubbin – “Bioprinting serves an unmet need in tissue engineering”

Karen Dubbin

Karen has studied biomaterials for almost 10 years during both her undergraduate career at MIT and graduate work at Stanford. 

She currently works at Aether, a 3D bioprinting startup, developing biomaterials for printing cells into living tissues for applications from drug development to full-organ printing. 

Nora Toure: Karen, could you let us know about your background and what brought you into 3D printing in the first place?

Karen Dubbin: I became interested in tissue engineering and regenerative medicine in high school, which led me to pursue a degree in materials science and engineering at MIT. I was drawn to materials due to their ability to influence cell behavior by providing physical and chemical cues. 

During my graduate work I became very interested in bioprinting because it serves an unmet need in tissue engineering: the ability to pattern cells into complex 3D architectures such as vasculature. The bulk of my PhD thesis focused on developing biomaterials specifically for 3D printing, termed “bio-inks,” which in turn led to my role at Aether.  

Read the rest at Women in 3D Printing

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest

Related Articles

Keep up to date on 3D Printing technologies

We're learning a lot about 3D printing, and So will you.

Subscribe to our mailing list and make better 3D print decisions.